Kinase Profiling Inhibitor Database

Inhibitor Structure Image Brutto MW Action Reference Reference 2 Patent Commercial Vendor Notes Results
AG1296 (Tyrphostin) C16H14N2O2 266.29 PDGF Kovalenko M. (1994) Cancer Res. 54 6106 Merck (Calbiochem) Download

Results as Barchart

View results as a bar chart
10µM

Results as Table

Screening Concentration: 10µM
Kinase % Activity Remaining Standard Deviation
MKK1 92 10
ERK1 101 17
ERK2 105 3
JNK1 101 11
JNK2 113 10
p38 alpha MAPK 91 5
p38 beta MAPK 95 4
p38 gamma MAPK 110 6
p38 delta MAPK 102 11
ERK8 86 12
RSK1 75 2
RSK2 97 6
PDK1 110 5
PKB alpha 104 2
PKB beta 98 0
SGK1 88 3
S6K1 106 17
PKA 96 5
ROCK 2 85 3
PRK2 95 9
PKC alpha 103 5
PKC zeta 94 1
PKD1 103 9
MSK1 102 1
MNK1 83 11
MNK2 74 0
MAPKAP-K2 107 11
PRAK 88 13
CAMKK beta 88 1
CAMK1 104 3
SmMLCK 84 26
PHK 101 10
CHK1 95 0
CHK2 93 9
GSK3 beta 113 4
CDK2-Cyclin A 91 8
PLK1 96 3
Aurora B 15 1
AMPK 80 1
MARK3 103 9
BRSK2 99 2
MELK 64 6
CK1 delta 54 2
CK2 80 2
DYRK1A 93 4
DYRK2 84 5
DYRK3 91 22
NEK2a 65 5
NEK6 116 27
IKK beta 101 3
IKK epsilon 85 2
TBK1 64 4
PIM1 104 8
PIM2 108 1
PIM3 79 1
SRPK1 95 0
EF2K 103 10
HIPK2 98 0
PAK4 69 1
PAK5 74 2
PAK6 97 2
MST2 79 6
MST4 105 10
Src 72 2
Lck 82 1
CSK 105 0
YES1 85 7
BTK 80 10
SYK 100 2
EPH-A2 98 14
EPH-B3 86 10
FGF-R1 94 18
IGF-1R 102 7
IR 70 7
IRR 75 9
VEGFR1 50 1

Do you need any help? Please get in touch and we’ll be happy to lend a hand.